GLP 28 day toxicity study of act-1 when applied topically to eyes twice daily for 28 days in dogs with a 14 day recovery period. POP: 09/01/2019 to 02/29/2020.
Ended Awarded Last action
- Contract number
- 75N95019F00090
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $547,622
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $547,622.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,908 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $85,323 | |
| Supplemental Agreement for work within scope | $24,296 | |
| Original award | $440,911 |
About this award
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to IIT Research Institute, a non-profit organization and the research and technology development arm of Illinois Institute of Technology. The $547,622.10 cost-plus-fixed-fee contract is for a 28-day topical eye toxicity study of the drug candidate ACT-1 in dogs, with a 14-day recovery period. This work supports NCATS' in vitro and in vivo toxicology studies program and provides preclinical drug testing services. IIT Research Institute holds multiple indefinite delivery/indefinite quantity (IDIQ) contract vehicles with NCATS and other NIH institutes, enabling the agency to leverage the organization's drug development expertise on an as-needed basis. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 75N95019F00090?
75N95019F00090 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2019.
How much is contract 75N95019F00090 worth?
The government has obligated $547,622 on 75N95019F00090.
Which agency awarded contract 75N95019F00090?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00090, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95019F00090 an order under another contract?
Yes. 75N95019F00090 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95019F00090 competed?
The extent of competition for 75N95019F00090 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award